Brain Cancer Study  British-based GW Pharmaceuticals received more good news regarding its cannabis-based drug development efforts. The drug-maker published positive Phase 2 data from an exploratory placebo-controlled study testing a combination treatment of active cannabis ingredients tetrahydrocannabinol and cannabidiol (THC: CBD)…